# Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

> **NCT00442351** · PHASE4 · TERMINATED · sponsor: **Organon and Co** · enrollment: 26 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Asmanex twisthaler
- **OTHER:** Placebo for Asmanex twisthaler

## Key facts

- **NCT ID:** NCT00442351
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Slow Enrollment
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442351, "Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00442351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*